Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Sepsis a Significant factor in Covid-19 Deaths

<< Previous

Bullboard Posts

Next >>

Post by mercedesmanon Dec 20, 2021 5:07pm

240 Views

Post# 34248396

Sepsis a Significant factor in Covid-19 Deaths

We often refer to COVID-19 as the novel coronavirus. That’s because this virus – SARS-CoV-2 – is a new type of coronavirus affecting humans. But now, a new report says that there is nothing novel, or new, about what is killing a lot of COVID-19 patients – Sepsis.

https://www.medmalfirm.com/news-and-updates/sepsis-factor-covid-19-deaths/

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season